Skip to content

Gastrointestinal amphicrine carcinoma: A Clinicopathologic Study of Five Cases

Gastrointestinal amphicrine carcinoma: A Clinicopathologic Study of Five Cases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102310
Enrollment
Unknown
Registered
2025-05-13
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric and colorectal AC is rare, and this tumor has unique histological features and immunophenotype. Combined with histological morphology, immunophenotype, AB-PAS special staining results are helpful for diagnosis and differential diagnosis.

Interventions

Gastrointestinal amphicrine carcinoma:NA

Sponsors

Ningbo clinical pathology diagnosis center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Gastric and colorectal cancers with bidirectional differentiation of adenocarcinoma and neuroendocrine carcinoma;

Exclusion criteria

Exclusion criteria: 1.Goblet cell adenocarcinoma; 2.MiNEN; 3.Poorly differentiated adenocarcinoma;

Design outcomes

Primary

MeasureTime frame
Clinicopathological features;Cytological morphology;

Countries

China

Contacts

Public ContactHairen Chen

Ningbo clinical pathology diagnosis center

294590575@qq.com+86 574 87651114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026